SCHEMBL3341999

SCHEMBL3341999

C/C=C/C(=O)OCC1=CC(O)C(O)C(O)C1=O

nearest known ligand 0.48

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11777188 1.00 GSTP1 (0.48) GSTP1
SCHEMBL11777173 1.00 GSTP1 (0.48) GSTP1
SCHEMBL16431077 0.67 AHCY (0.36)
SCHEMBL11780701 0.67 AHCY (0.36)
SCHEMBL31606946 0.67 AHCY (0.36)
SCHEMBL5496671 0.65 GSTP1 (1.00) GSTP1
SCHEMBL5496677 0.65 GSTP1 (1.00) GSTP1
SCHEMBL5335771 0.63 GSTP1 (0.36) GSTP1
SCHEMBL20211557 0.62 HCAR2 (0.51) GSTP1
SCHEMBL1070426 0.62 HCAR2 (0.71)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100162416-A1 Multi-stage stem cell carcinogenesis STEMLIFELINE, INC. (US) 2010-06-24 US disclosed
WO-2010037134-A2 MULTI-STAGE STEM CELL CARCINOGENESIS STEMLIFELINE, INC. (US) 2010-04-01 WO disclosed